The management of pregnant patients with antiphospholipid syndrome

被引：11

作者：

Cervera, R

Balasch, J

机构：

[1] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer,Fac Med, Dept Autoimmune Dis, E-08036 Barcelona, Spain

[2] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer,Fac Med, Inst Clin Gynaecol Obstet & Neonatol, E-08036 Barcelona, Spain

来源：

LUPUS | 2004年 / 13卷 / 09期

关键词：

antiphospholipid antibodies; antiphospholipid syndrome; aspirin; heparin; lupus anticoagulant; pregnancy loss;

D O I：

10.1191/0961203304lu1092oa

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recurrent pregnancy loss is now considered a treatable clinical condition associated with antiphospholipid antibodies. The management of pregnant patients with antiphospholipid syndrome is mainly based on the use of antiaggregant/ anticoagulant agents ( with aspirin and heparin) to prevent thrombosis in the uteroplacental circulation. Interventions with these drug therapies and monitored pregnancy have increased fetal survival.

引用

页码：683 / 687

页数：5

共 34 条

[1] LOW-DOSE ASPIRIN FOR PREVENTION OF PREGNANCY LOSSES IN WOMEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].

BALASCH, J ;

CARMONA, F ;

LOPEZSOTO, A ;

FONT, J ;

CREUS, M ;

FABREGUES, F ;

INGELMO, M ;

VANRELL, JA .

HUMAN REPRODUCTION, 1993, 8 (12) :2234-2239

[2] Reflections on the management of reproductive failure in the antiphospholipid syndrome - the clinician's perspective [J].

Balasch, J ;

Cervera, R .

LUPUS, 2002, 11 (08) :467-477

[3]

Balasch J., 2002, ANTIPHOSPHOLIPID SYN, P375

[4] Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy [J].

Botet, F ;

Romera, G ;

Montagut, P ;

Figueras, J ;

Carmona, F ;

Balasch, J .

JOURNAL OF PERINATAL MEDICINE, 1997, 25 (02) :192-196

[5] Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus.: A study of 60 cases [J].

Carmona, F ;

Font, J ;

Cervera, R ;

Muñoz, F ;

Cararach, V ;

Balasch, J .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 83 (02) :137-142

[6] Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies:: A multivariate analysis [J].

Carmona, F ;

Font, J ;

Azulay, M ;

Creus, M ;

Fábregues, F ;

Cervera, R ;

Puerto, B ;

Balasch, J .

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 46 (04) :274-279

[7] Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis [J].

Coomarasamy, A ;

Papaioannou, S ;

Gee, H ;

Khan, KS .

OBSTETRICS AND GYNECOLOGY, 2001, 98 (05) :861-866

[8] Prevention of fetal death in the antiphospholipid antibody syndrome [J].

Cowchock, S .

LUPUS, 1996, 5 (05) :467-472

[9] How to treat women with antiphospholipid antibodies in pregnancy? [J].

Derksen, RHWM ;

de Groot, G ;

Nieuwenhuis, HK ;

Christiaens, GCML .

ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (01) :1-3

[10]

Esplin MS, 2001, CLIN OBSTET GYNECOL, V44, P20

← 1 2 3 4 →